Lantadene A-induced apoptosis in human leukemia HL-60 cells

Indian Journal of Pharmacology

Volumn 39, Issue 3, 2007, Pages 140-144

  Sharma, M ^a   Sharma, P D ^a   Bansal, M P ^b   Singh, J ^c  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

^c CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Bcl 2 Bax; Caspase 3; DEVD CHO; Pentacyclic triterpenoid

Indexed keywords

CASPASE 3 INHIBITOR; DNA FRAGMENT; LANTADENE A; LANTANA CAMARA EXTRACT; PROTEIN BAX; PROTEIN BCL 2; TRITERPENOID; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL ASSAY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL SHAPE; CELL STRAIN HL 60; CELL STRUCTURE; CELL VIABILITY; CHROMATIN CONDENSATION; CHRONOPHARMACOLOGY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA STRUCTURE; DOWN REGULATION; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; LEUKEMIA CELL; PROTEIN EXPRESSION;

EID: 34447637984     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.33433     Document Type: Article

References (21)

1. Hidalgo A, Ffrench-Constant C. The control of cell number during central nervous system development in flies and mice. Mech Dev 2003;120:1311-25.
2. Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999;96:245-54.
3. Kucharczak J, Simmons M, Fan Y, Gelinas C. To be or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003;22:8961-82.
4. Cory S, Huang SC, Adams JM. The Bcl-2 family: Roles in cell survival and oncogenesis. Oncogene 2003;22:8590-107.
5. Reed JC. Apoptosis- regulating proteins as targets for drug discovery. Trends Mol Med 2001;7:314-9.
6. Degli Esposti M, Dive C. Mitochondrial membrane permeabilisation by Bax/Bak. Biochem Biophys Res Commun 2003;304:455-61.
7. Hu W, Kavanagh JJ. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 2003;4:721-9.
8. Connolly JD, Hill RA. Triterpenoids. Nat Prod Rep 2005;22:487-503.
9. Sharma OP, Vaid J, Sharma PD. Comparison of lantadenes and toxicity of different taxa of the lantana plant. J Chem Ecol 1991;17:2283-91.
10. Ghisalberti EL. Lantana camara (Verbenaceae). Fitoterapia 2000;71:467-86.
11. Sharma M, Sharma PD, Bansal MP. Chemopreventive effect of Lantana camara L. leaf extract on DMBA-induced squamous cell carcinoma of skin in Swiss albino mice. Pharmaceutical Biology 2007;45(2):145-48.
12. Sharma M, Sharma PD. Optimization of lantadene isolation and preparation of 22β-hydroxyoleanonic acid. Chem Nat Comp 2006;42:442-44.
13. Inada A, Nakanishi T, Tokuda H, Nishino H, Iwashina A, Sharma OP. Inhibitory effects of lantadenes and related terpenoids on Epstein - Barr virus activation. Planta Medica 1995;61:558-9.
14. Inada A, Nakanishi T, Tokuda H, Nishino H, Iwashina A, Sharma OP. Antitumor promoting activities of lantadenes on mouse skin tumors and mouse hepatic tumors, Planta Medica 1997;63:272-4.
15. Beeby PJ. Chemical modifications of triterpenes from Lantana camara, 22β-ester analogues of lantadenes A. Aust J Chem 1978;31:1313-22.
16. Mosmann T. Rapid calorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Met 1983;65:55-63.
17. 3/T- cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature (Lond) 1989;337:181-4.
18. Hyun PW, Hee CY, Won JC, Oh PJ, Kim K, Hyuck IJ, et al. Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem Biophys Res Commun 2003;300:230-5.
19. Earnshaw WC. Nuclear changes in apoptosis. Curr Opin Cell Biol 1995;7:337-43.
20. Oltvai ZN, Milliman CL, Korsemeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
21. Izban KF, Wrone Smith T, His ED, Schnitzer B, Quevedo ME, Alkan S. Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease: Lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease. Am J Pathol 1999;154:1439-47.